KASEY MCFARLING: Open Payments
NPI 1780925008 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 53 payments from 16 companies in 2025. Trend: 2023 $2,169 · 2024 $4,060 · 2025 $1,284
Food & beverage: $1,284
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $437 |
| Inspire Medical Systems, Inc. | 5 | $221 |
| GlaxoSmithKline, LLC. | 8 | $165 |
| GENZYME CORPORATION | 4 | $83 |
| Insmed, Inc. | 4 | $76 |
| Amgen Inc. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $47 |
| AtriCure, Inc. | 1 | $34 |
| Genentech USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: TEZSPIRE, INSPIRE, AIRSUPRA, NUCALA, DUPIXENT, Arikayce, FASENRA, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM.
Industry payments across VA — which companies pay providers there.
